Revolutionizing Drug Safety Screening with ValaDATE.AI™
ValaDATE.AI™ is the next-generation drug safety screening platform designed to identify and eliminate adverse drug reactions with unparalleled precision, ensuring safer patient treatments.
How ValaDATE.AI™ Transforms Drug Safety Screening
ValaDATE.AI™ (Vala's Deep Analytics for Toxicity and Efficacy AI) integrates cutting-edge human cell models, AI-powered analysis, and high-throughput imaging to deliver the most predictive drug safety screening.
- Human Cell Models – Tests drug effects on advanced human-relevant cell systems for accurate toxicity assessments.
- Kinetic Image Cytometer (KIC®) – Captures high-resolution, real-time cellular activity to detect early toxicity signals.
- AI-Powered Analysis (CyteSeer®) – Analyzes single-cell data to provide highly sensitive and precise toxicity predictions.
This groundbreaking approach accelerates drug development, reduces costs, and eliminates the need for unreliable animal testing.
Why ValaDATE.AI™ is the Future of Drug Safety Screening
Drug-induced cardiotoxicity is a leading cause of treatment failure and patient harm. ValaDATE.AI™'s flagship application, proph𝔼CG™, revolutionizes drug safety screening by accurately predicting cardiac risks before clinical trials.
The ValaDATE.AI™ Advantage:
✔ Human-Relevant – Replaces outdated animal studies for superior accuracy.
✔ Predictive Insights – Detects drug-induced changes in echo- and electrocardiogram (ECG) signals before patient exposure.
✔ Unmatched Precision – Identifies arrhythmia, QT prolongation, and heart arrest risks early in drug development.
✔ Faster & Cost-Effective – Reduces time and costs associated with traditional drug safety screening.
✔ Safer Drug Development – Minimizes adverse effects and regulatory failures.
By transforming drug toxicity and efficacy screening, ValaDATE.AI™ is setting a new standard for safe, efficient, and ethical drug development.
Key Benefits of ValaDATE.AI™ in Drug Safety Screening
ValaDATE.AI™ with proph𝔼CG™ sets the gold standard for cost-effective, rapid, and accurate drug safety screening.
Unmatched Accuracy – Predicts critical cardiac metrics (heart rate, QT prolongation, QRS intervals, arrhythmia, cardiac arrest) with 97% clinical predictivity.
Accelerated Decision-Making – Empowers earlier, data-driven decisions, reducing costs and time-to-market.
No Animal Testing – Replaces unreliable animal models with human-relevant data, improving ethical and scientific outcomes.
ValaDATE.AI™ by the Numbers
ValaDATE.AI™ is the most clinically predictive drug safety screening platform, capable of identifying and eliminating adverse drug reactions before they reach patients.
10,000x
more optical cellular data
20M
metrics analyzed per drug
7,000
wells screened per day
>4B
cell health data points per day
97%
clinical predictivity
Partner with Us in Advancing Drug Safety Screening
At Vala Discovery, we are redefining drug safety screening with AI-driven, human-relevant solutions. Pharma leaders and biotech innovators trust ValaDATE.AI™ to accelerate drug development while ensuring patient safety. Join us in shaping the future of safer, more effective treatments.